| Narendra Khanchandani, MD | |
|
28801 Plymouth Rd, Livonia, MI 48150-2385 | |
| (734) 266-2780 | |
| (734) 466-9615 |
| Full Name | Narendra Khanchandani |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 37 Years |
| Location | 28801 Plymouth Rd, Livonia, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215907753 | NPI | - | NPPES |
| 4667557 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 4301063625 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joe Mercy Hospital System Livonia | Livonia, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Mary Mercy Hospital Professional | 2365521226 | 34 |
News Archive
Working with human colon cancer cells and mice, researchers led by experts at the Johns Hopkins Kimmel Cancer Center say they have successfully blocked the activity of portions of a protein known as UHRF1 and restored the function of hundreds of cancer-fighting genes that became "misregulated" by the disease.
"Love and marriage," sang philosopher Frank Sinatra, "is an institute you can't disparage." Especially, a new Tel Aviv University study suggests, when a happy marriage may help to prevent fatal strokes in men.
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
Results of a phase 2 study published in The Lancet suggest that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS), which is currently untreatable.
› Verified 1 days ago
| Entity Name | St Mary Mercy Hospital Professional |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528145554 PECOS PAC ID: 2365521226 Enrollment ID: O20080502000426 |
News Archive
Working with human colon cancer cells and mice, researchers led by experts at the Johns Hopkins Kimmel Cancer Center say they have successfully blocked the activity of portions of a protein known as UHRF1 and restored the function of hundreds of cancer-fighting genes that became "misregulated" by the disease.
"Love and marriage," sang philosopher Frank Sinatra, "is an institute you can't disparage." Especially, a new Tel Aviv University study suggests, when a happy marriage may help to prevent fatal strokes in men.
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
Results of a phase 2 study published in The Lancet suggest that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS), which is currently untreatable.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Narendra Khanchandani, MD 28801 Plymouth Rd, Livonia, MI 48150-2385 Ph: (734) 266-2780 | Narendra Khanchandani, MD 28801 Plymouth Rd, Livonia, MI 48150-2385 Ph: (734) 266-2780 |
News Archive
Working with human colon cancer cells and mice, researchers led by experts at the Johns Hopkins Kimmel Cancer Center say they have successfully blocked the activity of portions of a protein known as UHRF1 and restored the function of hundreds of cancer-fighting genes that became "misregulated" by the disease.
"Love and marriage," sang philosopher Frank Sinatra, "is an institute you can't disparage." Especially, a new Tel Aviv University study suggests, when a happy marriage may help to prevent fatal strokes in men.
The Structural Genomics Consortium (SGC) and CHDI Foundation have entered into a unique open-access research collaboration to discover and characterize new drug targets for Huntington's disease (HD) using structural and chemical biology In this first partnership of its kind, SGC and CHDI have explicitly agreed not to file for patents on any of the collaborative research and to make all reagents and knowledge available without restriction to the wider research community, including pharmaceutical, biotech, and academic research groups.
With a $1 million grant from the W. M. Keck Foundation, neuroscience researchers at Washington State University and the University of Massachusetts Amherst will explore whether variations in brain levels of bacterial fragments can account for life's sleep/wake and 24-hour cycles, known as circadian rhythms.
Results of a phase 2 study published in The Lancet suggest that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS), which is currently untreatable.
› Verified 1 days ago
Mark Gregory Marrone, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18302 Middlebelt Rd, Livonia, MI 48152 Phone: 248-478-1500 Fax: 248-478-2798 | |
Jay Maurice Daitch, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 20206 Farmington Rd, Livonia, MI 48152 Phone: 248-476-4724 Fax: 248-476-7091 | |
Dr. Mark R. Villeneuve, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 14555 Levan Rd, Suite 202, Livonia, MI 48154 Phone: 734-542-4470 Fax: 734-542-4475 | |
Dr. John Krausman, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 20000 Farmington Rd, Bldg. E, Livonia, MI 48152 Phone: 248-474-1144 Fax: 248-474-1548 | |
Jenelle Hao-galera, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 36123 Schoolcraft Rd, Livonia, MI 48150 Phone: 734-793-6140 Fax: 734-402-0254 | |
Mark A Rasak, DO Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 17880 Farmington Rd, Livonia, MI 48152 Phone: 248-615-7300 Fax: 248-615-7333 | |
Maria B. Perry, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 36123 Schoolcraft Rd, Livonia, MI 48150 Phone: 734-464-0887 Fax: 734-402-0254 |